Visual Function in Carriers of X-Linked Retinitis Pigmentosa
Purpose To determine the frequency and severity of visual function loss in female carriers of X-linked retinitis pigmentosa (XLRP). Design Case series. Participants Two hundred seventy-six XLRP carriers with cross-sectional data (n = 242) and longitudinal data (n = 34; median follow-up, 16 years; fo...
Gespeichert in:
Veröffentlicht in: | Ophthalmology (Rochester, Minn.) Minn.), 2015-09, Vol.122 (9), p.1899-1906 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1906 |
---|---|
container_issue | 9 |
container_start_page | 1899 |
container_title | Ophthalmology (Rochester, Minn.) |
container_volume | 122 |
creator | Comander, Jason, MD, PhD Weigel-DiFranco, Carol, MA Sandberg, Michael A., PhD Berson, Eliot L., MD |
description | Purpose To determine the frequency and severity of visual function loss in female carriers of X-linked retinitis pigmentosa (XLRP). Design Case series. Participants Two hundred seventy-six XLRP carriers with cross-sectional data (n = 242) and longitudinal data (n = 34; median follow-up, 16 years; follow-up range, 3–37 years). Half of the carriers were from RPGR - or RP2 -genotyped families. Methods Retrospective medical records review. Main Outcome Measures Visual acuities, visual field areas, final dark adaptation thresholds, and full-field electroretinography (ERG) responses to 0.5-Hz and 30-Hz flashes. Results In genotyped families, 40% of carriers showed a baseline abnormality on at least 1 of 3 psychophysical tests. There was a wide range of function among carriers. For example, 3 of 121 (2%) genotyped carriers were legally blind because of poor visual acuity, some as young as 35 years. Visual fields were less affected than visual acuity. In all carriers, the average ERG amplitude to 30-Hz flashes was approximately 50% of normal, and the average exponential rate of amplitude loss over time was half that of XLRP males (3.7%/year vs. 7.4%/year, respectively). Among obligate carriers with affected fathers, sons, or both, 53 of 55 (96%) had abnormal baseline ERG results. Some carriers who initially had completely normal fundi in both eyes went on to experience moderately decreased vision, although not legal blindness. Among carriers with RPGR mutations, those with mutations in ORF15, compared with those in exons 1–14, had worse final dark adaptation thresholds and lower 0.5-Hz and 30-Hz ERG amplitudes. Conclusions Most carriers of XLRP had mildly or moderately reduced visual function but rarely became legally blind. In most cases, obligate carriers could be identified by ERG testing. Carriers of RPGR ORF15 mutations tended to have worse visual function than carriers of RPGR exon 1 through 14 mutations. Because XLRP carrier ERG amplitudes and decay rates over time were on average half of those of affected men, these observations were consistent with the Lyon hypothesis of random X-inactivation. |
doi_str_mv | 10.1016/j.ophtha.2015.05.039 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4562908</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0161642015005382</els_id><sourcerecordid>1706577958</sourcerecordid><originalsourceid>FETCH-LOGICAL-c654t-ad9afcdb9c6c2d5a9b9cd564bebbb0c7e18ee7085aded9065397213e40fc442f3</originalsourceid><addsrcrecordid>eNqFkVuLFDEQhYMo7rj6D0T60ZceK9eegAgyuCoMKN7wLaST6p3M9iRj0r2w_94Ms66XF6EggVSdU_kOIU8pLClQ9WK3TIfttLVLBlQuoRbX98iCSqFb0VF-nyxqG22VYHBGHpWyAwCluHhIzpiigkvBFuTlt1BmOzYXc3RTSLEJsVnbnAPm0qSh-d5uQrxC33zCKcQwhdJ8DJd7jFMq9jF5MNix4JPb85x8vXjzZf2u3Xx4-379etM6JcXUWq_t4HyvnXLMS6vrzUsleuz7HlyHdIXYwUpaj16Dklx3jHIUMDgh2MDPyauT7mHu9-hddc92NIcc9jbfmGSD-fslhq25TNdGSMU0rKrA81uBnH7MWCazD8XhONqIaS6GdtW167Q8topTq8uplIzDnQ0FcwRvduYE3hzBG6jFdR179ueKd0O_SP_-A1ZQ1xWvKS5gdOhDRjcZn8L_HP4VcGNNxNnxCm-w7NKcYw3BUFOYAfP5GP4xeyoBJF8x_hM5d6yz</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1706577958</pqid></control><display><type>article</type><title>Visual Function in Carriers of X-Linked Retinitis Pigmentosa</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Comander, Jason, MD, PhD ; Weigel-DiFranco, Carol, MA ; Sandberg, Michael A., PhD ; Berson, Eliot L., MD</creator><creatorcontrib>Comander, Jason, MD, PhD ; Weigel-DiFranco, Carol, MA ; Sandberg, Michael A., PhD ; Berson, Eliot L., MD</creatorcontrib><description>Purpose To determine the frequency and severity of visual function loss in female carriers of X-linked retinitis pigmentosa (XLRP). Design Case series. Participants Two hundred seventy-six XLRP carriers with cross-sectional data (n = 242) and longitudinal data (n = 34; median follow-up, 16 years; follow-up range, 3–37 years). Half of the carriers were from RPGR - or RP2 -genotyped families. Methods Retrospective medical records review. Main Outcome Measures Visual acuities, visual field areas, final dark adaptation thresholds, and full-field electroretinography (ERG) responses to 0.5-Hz and 30-Hz flashes. Results In genotyped families, 40% of carriers showed a baseline abnormality on at least 1 of 3 psychophysical tests. There was a wide range of function among carriers. For example, 3 of 121 (2%) genotyped carriers were legally blind because of poor visual acuity, some as young as 35 years. Visual fields were less affected than visual acuity. In all carriers, the average ERG amplitude to 30-Hz flashes was approximately 50% of normal, and the average exponential rate of amplitude loss over time was half that of XLRP males (3.7%/year vs. 7.4%/year, respectively). Among obligate carriers with affected fathers, sons, or both, 53 of 55 (96%) had abnormal baseline ERG results. Some carriers who initially had completely normal fundi in both eyes went on to experience moderately decreased vision, although not legal blindness. Among carriers with RPGR mutations, those with mutations in ORF15, compared with those in exons 1–14, had worse final dark adaptation thresholds and lower 0.5-Hz and 30-Hz ERG amplitudes. Conclusions Most carriers of XLRP had mildly or moderately reduced visual function but rarely became legally blind. In most cases, obligate carriers could be identified by ERG testing. Carriers of RPGR ORF15 mutations tended to have worse visual function than carriers of RPGR exon 1 through 14 mutations. Because XLRP carrier ERG amplitudes and decay rates over time were on average half of those of affected men, these observations were consistent with the Lyon hypothesis of random X-inactivation.</description><identifier>ISSN: 0161-6420</identifier><identifier>EISSN: 1549-4713</identifier><identifier>DOI: 10.1016/j.ophtha.2015.05.039</identifier><identifier>PMID: 26143542</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Dark Adaptation ; Electroretinography ; Eye Proteins - genetics ; Female ; Genetic Association Studies ; Genetic Diseases, X-Linked - physiopathology ; Genotyping Techniques ; Heterozygote ; Humans ; Infant ; Intracellular Signaling Peptides and Proteins - genetics ; Membrane Proteins - genetics ; Middle Aged ; Ophthalmology ; Photic Stimulation ; Retina - physiopathology ; Retinitis Pigmentosa - genetics ; Retinitis Pigmentosa - physiopathology ; Retrospective Studies ; Vision Disorders - physiopathology ; Visual Acuity - physiology ; Visual Fields - physiology</subject><ispartof>Ophthalmology (Rochester, Minn.), 2015-09, Vol.122 (9), p.1899-1906</ispartof><rights>American Academy of Ophthalmology</rights><rights>2015 American Academy of Ophthalmology</rights><rights>Copyright © 2015 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c654t-ad9afcdb9c6c2d5a9b9cd564bebbb0c7e18ee7085aded9065397213e40fc442f3</citedby><cites>FETCH-LOGICAL-c654t-ad9afcdb9c6c2d5a9b9cd564bebbb0c7e18ee7085aded9065397213e40fc442f3</cites><orcidid>0000-0002-4257-7145</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ophtha.2015.05.039$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,777,781,882,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26143542$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Comander, Jason, MD, PhD</creatorcontrib><creatorcontrib>Weigel-DiFranco, Carol, MA</creatorcontrib><creatorcontrib>Sandberg, Michael A., PhD</creatorcontrib><creatorcontrib>Berson, Eliot L., MD</creatorcontrib><title>Visual Function in Carriers of X-Linked Retinitis Pigmentosa</title><title>Ophthalmology (Rochester, Minn.)</title><addtitle>Ophthalmology</addtitle><description>Purpose To determine the frequency and severity of visual function loss in female carriers of X-linked retinitis pigmentosa (XLRP). Design Case series. Participants Two hundred seventy-six XLRP carriers with cross-sectional data (n = 242) and longitudinal data (n = 34; median follow-up, 16 years; follow-up range, 3–37 years). Half of the carriers were from RPGR - or RP2 -genotyped families. Methods Retrospective medical records review. Main Outcome Measures Visual acuities, visual field areas, final dark adaptation thresholds, and full-field electroretinography (ERG) responses to 0.5-Hz and 30-Hz flashes. Results In genotyped families, 40% of carriers showed a baseline abnormality on at least 1 of 3 psychophysical tests. There was a wide range of function among carriers. For example, 3 of 121 (2%) genotyped carriers were legally blind because of poor visual acuity, some as young as 35 years. Visual fields were less affected than visual acuity. In all carriers, the average ERG amplitude to 30-Hz flashes was approximately 50% of normal, and the average exponential rate of amplitude loss over time was half that of XLRP males (3.7%/year vs. 7.4%/year, respectively). Among obligate carriers with affected fathers, sons, or both, 53 of 55 (96%) had abnormal baseline ERG results. Some carriers who initially had completely normal fundi in both eyes went on to experience moderately decreased vision, although not legal blindness. Among carriers with RPGR mutations, those with mutations in ORF15, compared with those in exons 1–14, had worse final dark adaptation thresholds and lower 0.5-Hz and 30-Hz ERG amplitudes. Conclusions Most carriers of XLRP had mildly or moderately reduced visual function but rarely became legally blind. In most cases, obligate carriers could be identified by ERG testing. Carriers of RPGR ORF15 mutations tended to have worse visual function than carriers of RPGR exon 1 through 14 mutations. Because XLRP carrier ERG amplitudes and decay rates over time were on average half of those of affected men, these observations were consistent with the Lyon hypothesis of random X-inactivation.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Dark Adaptation</subject><subject>Electroretinography</subject><subject>Eye Proteins - genetics</subject><subject>Female</subject><subject>Genetic Association Studies</subject><subject>Genetic Diseases, X-Linked - physiopathology</subject><subject>Genotyping Techniques</subject><subject>Heterozygote</subject><subject>Humans</subject><subject>Infant</subject><subject>Intracellular Signaling Peptides and Proteins - genetics</subject><subject>Membrane Proteins - genetics</subject><subject>Middle Aged</subject><subject>Ophthalmology</subject><subject>Photic Stimulation</subject><subject>Retina - physiopathology</subject><subject>Retinitis Pigmentosa - genetics</subject><subject>Retinitis Pigmentosa - physiopathology</subject><subject>Retrospective Studies</subject><subject>Vision Disorders - physiopathology</subject><subject>Visual Acuity - physiology</subject><subject>Visual Fields - physiology</subject><issn>0161-6420</issn><issn>1549-4713</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkVuLFDEQhYMo7rj6D0T60ZceK9eegAgyuCoMKN7wLaST6p3M9iRj0r2w_94Ms66XF6EggVSdU_kOIU8pLClQ9WK3TIfttLVLBlQuoRbX98iCSqFb0VF-nyxqG22VYHBGHpWyAwCluHhIzpiigkvBFuTlt1BmOzYXc3RTSLEJsVnbnAPm0qSh-d5uQrxC33zCKcQwhdJ8DJd7jFMq9jF5MNix4JPb85x8vXjzZf2u3Xx4-379etM6JcXUWq_t4HyvnXLMS6vrzUsleuz7HlyHdIXYwUpaj16Dklx3jHIUMDgh2MDPyauT7mHu9-hddc92NIcc9jbfmGSD-fslhq25TNdGSMU0rKrA81uBnH7MWCazD8XhONqIaS6GdtW167Q8topTq8uplIzDnQ0FcwRvduYE3hzBG6jFdR179ueKd0O_SP_-A1ZQ1xWvKS5gdOhDRjcZn8L_HP4VcGNNxNnxCm-w7NKcYw3BUFOYAfP5GP4xeyoBJF8x_hM5d6yz</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Comander, Jason, MD, PhD</creator><creator>Weigel-DiFranco, Carol, MA</creator><creator>Sandberg, Michael A., PhD</creator><creator>Berson, Eliot L., MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4257-7145</orcidid></search><sort><creationdate>20150901</creationdate><title>Visual Function in Carriers of X-Linked Retinitis Pigmentosa</title><author>Comander, Jason, MD, PhD ; Weigel-DiFranco, Carol, MA ; Sandberg, Michael A., PhD ; Berson, Eliot L., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c654t-ad9afcdb9c6c2d5a9b9cd564bebbb0c7e18ee7085aded9065397213e40fc442f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Dark Adaptation</topic><topic>Electroretinography</topic><topic>Eye Proteins - genetics</topic><topic>Female</topic><topic>Genetic Association Studies</topic><topic>Genetic Diseases, X-Linked - physiopathology</topic><topic>Genotyping Techniques</topic><topic>Heterozygote</topic><topic>Humans</topic><topic>Infant</topic><topic>Intracellular Signaling Peptides and Proteins - genetics</topic><topic>Membrane Proteins - genetics</topic><topic>Middle Aged</topic><topic>Ophthalmology</topic><topic>Photic Stimulation</topic><topic>Retina - physiopathology</topic><topic>Retinitis Pigmentosa - genetics</topic><topic>Retinitis Pigmentosa - physiopathology</topic><topic>Retrospective Studies</topic><topic>Vision Disorders - physiopathology</topic><topic>Visual Acuity - physiology</topic><topic>Visual Fields - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Comander, Jason, MD, PhD</creatorcontrib><creatorcontrib>Weigel-DiFranco, Carol, MA</creatorcontrib><creatorcontrib>Sandberg, Michael A., PhD</creatorcontrib><creatorcontrib>Berson, Eliot L., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Ophthalmology (Rochester, Minn.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Comander, Jason, MD, PhD</au><au>Weigel-DiFranco, Carol, MA</au><au>Sandberg, Michael A., PhD</au><au>Berson, Eliot L., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Visual Function in Carriers of X-Linked Retinitis Pigmentosa</atitle><jtitle>Ophthalmology (Rochester, Minn.)</jtitle><addtitle>Ophthalmology</addtitle><date>2015-09-01</date><risdate>2015</risdate><volume>122</volume><issue>9</issue><spage>1899</spage><epage>1906</epage><pages>1899-1906</pages><issn>0161-6420</issn><eissn>1549-4713</eissn><abstract>Purpose To determine the frequency and severity of visual function loss in female carriers of X-linked retinitis pigmentosa (XLRP). Design Case series. Participants Two hundred seventy-six XLRP carriers with cross-sectional data (n = 242) and longitudinal data (n = 34; median follow-up, 16 years; follow-up range, 3–37 years). Half of the carriers were from RPGR - or RP2 -genotyped families. Methods Retrospective medical records review. Main Outcome Measures Visual acuities, visual field areas, final dark adaptation thresholds, and full-field electroretinography (ERG) responses to 0.5-Hz and 30-Hz flashes. Results In genotyped families, 40% of carriers showed a baseline abnormality on at least 1 of 3 psychophysical tests. There was a wide range of function among carriers. For example, 3 of 121 (2%) genotyped carriers were legally blind because of poor visual acuity, some as young as 35 years. Visual fields were less affected than visual acuity. In all carriers, the average ERG amplitude to 30-Hz flashes was approximately 50% of normal, and the average exponential rate of amplitude loss over time was half that of XLRP males (3.7%/year vs. 7.4%/year, respectively). Among obligate carriers with affected fathers, sons, or both, 53 of 55 (96%) had abnormal baseline ERG results. Some carriers who initially had completely normal fundi in both eyes went on to experience moderately decreased vision, although not legal blindness. Among carriers with RPGR mutations, those with mutations in ORF15, compared with those in exons 1–14, had worse final dark adaptation thresholds and lower 0.5-Hz and 30-Hz ERG amplitudes. Conclusions Most carriers of XLRP had mildly or moderately reduced visual function but rarely became legally blind. In most cases, obligate carriers could be identified by ERG testing. Carriers of RPGR ORF15 mutations tended to have worse visual function than carriers of RPGR exon 1 through 14 mutations. Because XLRP carrier ERG amplitudes and decay rates over time were on average half of those of affected men, these observations were consistent with the Lyon hypothesis of random X-inactivation.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26143542</pmid><doi>10.1016/j.ophtha.2015.05.039</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-4257-7145</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0161-6420 |
ispartof | Ophthalmology (Rochester, Minn.), 2015-09, Vol.122 (9), p.1899-1906 |
issn | 0161-6420 1549-4713 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4562908 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adolescent Adult Aged Aged, 80 and over Child Child, Preschool Dark Adaptation Electroretinography Eye Proteins - genetics Female Genetic Association Studies Genetic Diseases, X-Linked - physiopathology Genotyping Techniques Heterozygote Humans Infant Intracellular Signaling Peptides and Proteins - genetics Membrane Proteins - genetics Middle Aged Ophthalmology Photic Stimulation Retina - physiopathology Retinitis Pigmentosa - genetics Retinitis Pigmentosa - physiopathology Retrospective Studies Vision Disorders - physiopathology Visual Acuity - physiology Visual Fields - physiology |
title | Visual Function in Carriers of X-Linked Retinitis Pigmentosa |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T03%3A56%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Visual%20Function%20in%20Carriers%20of%20X-Linked%20Retinitis%20Pigmentosa&rft.jtitle=Ophthalmology%20(Rochester,%20Minn.)&rft.au=Comander,%20Jason,%20MD,%20PhD&rft.date=2015-09-01&rft.volume=122&rft.issue=9&rft.spage=1899&rft.epage=1906&rft.pages=1899-1906&rft.issn=0161-6420&rft.eissn=1549-4713&rft_id=info:doi/10.1016/j.ophtha.2015.05.039&rft_dat=%3Cproquest_pubme%3E1706577958%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1706577958&rft_id=info:pmid/26143542&rft_els_id=1_s2_0_S0161642015005382&rfr_iscdi=true |